Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients

NCT05580887 is registered in ClinicalTrials.gov with Moscow Clinical Scientific Center as lead sponsor.

NCT NCT05580887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05580887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients
Lead sponsor
Moscow Clinical Scientific Center
Phase
Observational
Overall status
Unknown status
Start date
May 12, 2022
Completion date
August 31, 2025
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, pancreas cancer